Global Next Generation Sequencing Market (2021 to 2028) – Share, Size, Trends, Industry Analysis Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Next Generation Sequencing Market Share, Size, Trends, Industry Analysis Report, By Application; By Technology; By Product; By End-Use; By Regions; Segment Forecast, 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

The global next generation sequencing market expected to reach US$ 25.85 billion by 2028, according to the study.

This report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global next-generation sequencing market is anticipated to grow owing to advancements in both technology and genetic data analysis through the use of bioinformatics and other computational tools. Market players are focusing on developing automated sequencers equipped with high speed and accuracy. Moreover, significant investments in start-ups causing intense competition, thereby reducing the cost of sequencing. This has also enabled increased adoption in emerging nations.

The global next-generation sequencing market is fragmented based on application, technology, product, end-use, and region. In terms of application, the market is segmented into drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others.

The technology market segment is further divided into the whole genome, targeted sequencing & re-sequencing, whole exome, RNA sequencing, chip sequencing, de novo sequencing, and methyl sequencing. The product market segment is further divided into instruments, reagents & consumables, and services. The end-use market segment is further divided into healthcare institutions, academics, biotech & pharma firms, and others.

List of Key Players

• QIAGEN
• Thermo Fisher Scientific Inc.
• F Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies
• Genomatix GmbH
• PierianDx
• DNASTAR, Inc.
• Eurofins GATC Biotech GmbH
• Perkin Elmer, Inc.
• BGI
• Bio-Rad Laboratories, Inc.

Segment Highlights

• Infectious diseases segment is estimated to hold a major share in the global next generation sequencing market, owing to increasing usage of NGS in infectious diseases. Genetic screening segment is expected to expand at highest CAGR during the forecast.
• Based on technology, the target sequencing segment is projected to constitute almost half of the market in 2028. This can be attributed to the fact that concerned sequencing technique offers cost effective approach and increased market activities.
• North America region is dominating in the global next generation sequencing market, holding almost one third of the market share throughout forecast period. Recent spike in COVID-19 deaths in the U.S. and government funded genetic studies favoured the region’s growth.
• The players including QIAGEN, Oxford Nanopore Technologies, and Thermo Fisher Scientific Inc. together held a significant market share of global next generation sequencing industry in year 2020.

Key Topics Covered:

1. Introduction

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview

3.1.1. Data Mining

3.2. Data Sources

3.2.1. Primary Sources

3.2.2. Secondary Sources

4. Next Generation Sequencing Market Insights

4.1. Next Generation Sequencing – Industry snapshot

4.2. Next Generation Sequencing Market Dynamics

4.2.1. Drivers and Opportunities

4.2.1.1. Declining cost of sequencing

4.2.1.2. Miniaturization of Instruments

4.2.2. Restraints and Challenges

4.2.2.1. High upfront costs

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers (Moderate)

4.3.2. Threats of New Entrants: (Low)

4.3.3. Bargaining Power of Buyers (Moderate)

4.3.4. Threat of Substitute (Moderate)

4.3.5. Rivalry among existing firms (High)

4.4. PESTLE Analysis

4.5. Next Generation Sequencing Market Industry trends

5. Next Generation Sequencing Market Assessment by Application

6. Global Next Generation Sequencing Market, by Technology

7. Global Next Generation Sequencing Market, by Product

8. Next Generation Sequencing Market Assessment by End Use

9. Next Generation Sequencing Market Assessment by Geography

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis

10.1.1. Expansion

10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/3s6cv7

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900